Login / Signup
Treatment of Helicobacter pylori with potassium competitive acid blockers: A systematic review and meta-analysis.
Joseph Edwin Kanu
Jonathan Soldera
Published in:
World journal of gastroenterology (2024)
, positioning it as a highly effective first-line regimen. Additionally, TPZ-based triple therapy was non-inferior to classical PPI triple therapy.
Keyphrases
</>
helicobacter pylori
helicobacter pylori infection
stem cells
mesenchymal stem cells
angiotensin converting enzyme